Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Artefactual skin disorder involves self-inflicted skin lesions linked to mental health issues, needing combined medical and psychological treatment.

Deep learning and explainable AI are improving scalp disorder diagnosis, but challenges in transparency and data quality remain.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Older adults often have skin problems due to aging, and treating these conditions requires attention to both physical and mental health.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.